Advances in monitoring of aspirin therapy

Area of Science:

• Cardiology
• Pharmacology
• Hematology

Background:

• Aspirin is proven to reduce vascular death by ~15% and non-fatal events by ~30% in cardiovascular patients.
• Aspirin's benefit is countered by a dose-dependent increase in bleeding risk.
• Guidelines recommend the lowest effective aspirin dose to mitigate bleeding, necessitating therapy monitoring.

Purpose of the Study:

• To review the utility of platelet function testing in patients on aspirin therapy.
• To explore the clinical impact of variable platelet reactivity to aspirin.
• To discuss mechanisms of suboptimal platelet inhibition and future management strategies for aspirin therapy.

Main Methods:

• Review of recent literature on platelet function assays in aspirin-treated patients.
• Analysis of studies examining aspirin's impact on platelet reactivity.
• Discussion of clinical outcomes related to aspirin response variability.

Main Results:

• Platelet function testing shows variability in aspirin's antiplatelet effect among patients.
• Suboptimal platelet inhibition can occur due to various mechanisms.
• Personalized aspirin dosing based on platelet function may optimize outcomes.

Conclusions:

• Platelet function testing offers potential for personalized aspirin therapy.
• Understanding variability in aspirin response is crucial for managing cardiovascular risk and bleeding.
• Further research is needed to refine aspirin management strategies.